Identification of the transcription factor MAZ as a regulator of erythropoiesis.
Darya DeenFalk ButterDeborah E DanielsIvan Ferrer-VicensDaniel C J FergusonMichelle L HollandVasiliki SamaraJacqueline A Sloane-StanleyHelena AyyubMatthias MannJan FrayneDavid GarrickDouglas VernimmenPublished in: Blood advances (2021)
Erythropoiesis requires a combination of ubiquitous and tissue-specific transcription factors (TFs). Here, through DNA affinity purification followed by mass spectrometry, we have identified the widely expressed protein MAZ (Myc-associated zinc finger) as a TF that binds to the promoter of the erythroid-specific human α-globin gene. Genome-wide mapping in primary human erythroid cells revealed that MAZ also occupies active promoters as well as GATA1-bound enhancer elements of key erythroid genes. Consistent with an important role during erythropoiesis, knockdown of MAZ reduces α-globin expression in K562 cells and impairs differentiation in primary human erythroid cells. Genetic variants in the MAZ locus are associated with changes in clinically important human erythroid traits. Taken together, these findings reveal the zinc-finger TF MAZ to be a previously unrecognized regulator of the erythroid differentiation program.
Keyphrases
- transcription factor
- genome wide
- endothelial cells
- induced apoptosis
- mass spectrometry
- cell cycle arrest
- induced pluripotent stem cells
- pluripotent stem cells
- dna methylation
- poor prognosis
- high resolution
- binding protein
- endoplasmic reticulum stress
- copy number
- cell death
- liquid chromatography
- small molecule
- signaling pathway
- cell proliferation
- single molecule
- amino acid
- ms ms
- circulating tumor cells